Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial-Reference-Cited by-同舟云学术

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial

Published:2021-01-27 Issue:2 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Xu Xiaowei¹,Jiang Wanli²,Chen Lijun¹^ORCID,Xu Zhenyu³,Zhang Qiang³,Zhu Mengfei⁴,Ye Peng²,Li Hang³,Yu Liang¹^ORCID,Zhou Xiaoyang²,Zhou Chenliang²,Chen Xiaobei²,Zheng Xiaoqin¹,Xu Kaijin¹,Cai Hongliu¹,Zheng Shufa¹,Jiang Wubian²,Wu Xiaojun²,Li Dong²,Chen Lu³,Luo Qingqing³,Wang Yingyan³,Qu Jingjing⁵,Li Yifei¹,Zheng Wendi¹,Jiang Yingan²,Tang Lingling⁴,Xiang Charlie¹^ORCID,Li Lanjuan¹⁴

Affiliation:

1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious Diseases Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases The First Affiliated Hospital College of Medicine Zhejiang University Hangzhou Zhejiang P. R. China

2. Department of Infectious Diseases Renmin Hospital of Wuhan University Wuhan Hebei P.R. China

3. Innovative Precision Medicine (IPM) Group Hangzhou Zhejiang P. R. China

4. Shulan (Hangzhou) Hospital, Zhejiang Shuren University Shulan International Medical College Hangzhou Zhejiang P. R. China

5. Department of Respiratory Disease Thoracic Disease Centre The First Affiliated Hospital College of Medicine Zhejiang University Hangzhou Zhejiang P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.297

Reference100 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. A novel coronavirus outbreak of global health concern